王薇, 李峥, 刘军廷, 夏兰芳, 张润华, 陈晨, 汪立杰, 梁瑞英, 郑文静, 亓晓, 么鸿雁. 健康测量与评价研究进展[J]. 疾病监测, 2021, 36(3): 219-224. doi: 10.3784/jbjc.202010270368
引用本文: 王薇, 李峥, 刘军廷, 夏兰芳, 张润华, 陈晨, 汪立杰, 梁瑞英, 郑文静, 亓晓, 么鸿雁. 健康测量与评价研究进展[J]. 疾病监测, 2021, 36(3): 219-224. doi: 10.3784/jbjc.202010270368
Wang Wei, Li Zheng, Liu Junting, Xia Lanfang, Zhang Runhua, Chen Chen, Wang Lijie, Liang Ruiying, Zheng Wenjing, Qi Xiao, Yao Hongyan. Progress in research of population health measurement and evaluation[J]. Disease Surveillance, 2021, 36(3): 219-224. doi: 10.3784/jbjc.202010270368
Citation: Wang Wei, Li Zheng, Liu Junting, Xia Lanfang, Zhang Runhua, Chen Chen, Wang Lijie, Liang Ruiying, Zheng Wenjing, Qi Xiao, Yao Hongyan. Progress in research of population health measurement and evaluation[J]. Disease Surveillance, 2021, 36(3): 219-224. doi: 10.3784/jbjc.202010270368

健康测量与评价研究进展

doi: 10.3784/jbjc.202010270368
基金项目: 国家重点研发计划(No. 2018YFC1315305);中国疾病预防控制中心科研项目(No. JY18-2-22)
详细信息
    作者简介:

    王薇,女,安徽省马鞍山市人,在读博士,主要从事慢性病流行病学与统计方法应用研究,Email:wangw917@126.com

    通讯作者:

    么鸿雁,Tel:010–58900522,Email:yaohy@chinacdc.cn

  • 中图分类号: R211; R181.3

Progress in research of population health measurement and evaluation

Funds: This study was supported by National Key Research and Development Program (No. 2018YFC1315305) and China CDC’s Scientific Research Project (No. JY18-2-22)
More Information
  • 摘要: 随着人群疾病谱的变化和医学模式的转变,健康测量与评价的范畴、内容、方法及指标发生了深刻的变化。本研究将从健康理论的发展、健康测量与评价理论、健康测量与评价指标、大数据在健康测量与评价中的应用等方面介绍健康测量与评价的研究进展,为健康信息的丰富、完善和比较以及卫生政策的制定提供重要参考依据。
  • [1] 谭红专. 现代流行病学[M]. 3版. 北京: 人民卫生出版社, 2019.

    Tan HZ. Modern epidemiology[M]. 3th ed. Beijing: People′s Medical Publishing House, 2019.
    [2] Larson JS. The measurement of health: concepts and indicators[M]. New York: Greenwood Press, 1991.
    [3] World Health Organization. Constitution of the World Health Organization[EB/OL]. (2006−10−09)[2020−09−11]. https://www.who.int/publications/m/item/constitution-of-the-world-health-organization.
    [4] Hahn D, Payne W, Lucas E. Focus on health loose leaf edition[M]. 11th ed. New York: McGraw-Hill Higher Education, 2013.
    [5] 李怀龙. 可测性的确认: 心理与教育测量的认识论基础[J]. 心理学探新,2015,35(4):303–306. DOI:10.3969/j.issn.1003−5184.2015.04.003.

    Li HL. The confirnation of measurability: epistenological foundation of psychological and educational measurenent[J]. Psychol Explorat, 2015, 35(4): 303–306. DOI: 10.3969/j.issn.1003−5184.2015.04.003.
    [6] Hahn DB, Payne WA, Lucas EB. Focus on health[M]. 11th ed. Boston: McGraw-Hill Education, 2012: 9–12.
    [7] 李鲁, 王红妹, 沈毅. SF-36健康调查量表中文版的研制及其性能测试[J]. 中华预防医学杂志,2002,36(2):109–113. DOI:10.3760/j:issn:0253−9624.2002.02.011.

    Li L, Wang HM, Shen Y. Development and psychometric tests of a Chinese version of the SF-36 health survey scales[J]. Chin J Prev Med, 2002, 36(2): 109–113. DOI: 10.3760/j:issn:0253−9624.2002.02.011.
    [8] Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D[J]. Qual Life Res, 2005, 14(6): 1523–1532. DOI: 10.1007/s11136−004−7713−0.
    [9] Ferreira LN, Ferreira PL, Pereira LN, et al. Exploring the consistency of the SF-6D[J]. Value Health, 2013, 16(6): 1023–1031. DOI:  10.1016/j.jval.2013.06.018.
    [10] The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life[J]. Health Policy, 1990, 16(3): 199–208. DOI: 10.1016/0168−8510(90)90421−9.
    [11] Aaronson NK, Cull A, Kaasa S, et al. The EORTC modular approach to quality of life assessment in oncology[J]. Int J Ment Health, 1994, 23(2): 75–96. DOI:  10.1080/00207411.1994.11449284.
    [12] Brucker PS, Yost K, Cashy J, et al. General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G)[J]. Eval Health Prof, 2005, 28(2): 192–211. DOI:  10.1177/0163278705275341.
    [13] GBD 2017 Mortality Collaborators. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018, 392(10159): 1684–1735. DOI: 10.1016/S0140−6736(18)31891−9.
    [14] GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018, 392(10159): 1859–1922. DOI: 10.1016/S0140−6736(18)32335−3.
    [15] 陈文. 卫生经济学[M]. 4版. 北京: 人民卫生出版社, 2017.

    Chen W. Health economics[M]. 4th ed. Beijing: People′s Medical Publishing House, 2017.
    [16] 李晓松. 卫生统计学[M]. 8版. 北京: 人民卫生出版社, 2017.

    Li XS. Health statistics[M]. 8th ed. Beijing: People′s Medical Publishing House, 2017.
    [17] 全国爱国卫生运动委员会. 全国爱卫会关于印发全国健康城市评价指标体系(2018版)的通知[EB/OL]. (2018−03−28)[2020−08−10]. http://www.nhfpc.gov.cn/jkj/s5899/201804/fd8c6a7ef3bd41aa9c24e978f5c12db4.shtml.

    National Patriotic Health Campaign Committee. Announcement on National Healthy city Evaluation system published by China patriotic public health campaign committee[EB/OL]. (2018−03−28)[2020−08−10]. http://www.nhfpc.gov.cn/jkj/s5899/201804/fd8c6a7ef3bd41aa9c24e978f5c12db4.shtml.
    [18] 肖月, 赵琨, 薛明, 等. “健康中国2030”综合目标及指标体系研究[J]. 卫生经济研究,2017(4):3–7. DOI:10.14055/j.cnki.33−1056/f.20170330.019.

    Xiao Y, Zhao K, Xue M, et al. Study on the comprehensive goal and index system of Healthy China 2030[J]. Health Econom Res, 2017(4): 3–7. DOI: 10.14055/j.cnki.33−1056/f.20170330.019.
    [19] 中华人民共和国中央人民政府. 中共中央 国务院印发《“健康中国2030”规划纲要》[EB/OL]. (2016−10−25)[2020−08−08]. http://www.gov.cn/xinwen/2016-10/25/content_5124174.htm.

    The State Council of the People′s Republic of China. “Healthy China 2030 Planning” was published by the central committee of the communist party of China and the state Council[EB/OL]. (2016−10−25)[2020−08−08]. http://www.gov.cn/xinwen/2016-10/25/content_5124174.htm.
    [20] 中华人民共和国中央人民政府. 健康中国行动(2019-2030年)[EB/OL]. (2019−07−15)[2020−08−08]. http://www.gov.cn/xinwen/2019-07/15/content_5409694.htm.

    The State Council of the People′s Republic of China. Health China action (2019–2030)[EB/OL]. (2019−07−15)[2020−08−08]. http://www.gov.cn/xinwen/2019-07/15/content_5409694.htm.
    [21] 亓晓, 张勇, 万霞, 等. 公共卫生政策评价设计思路及其应用[J]. 中国预防医学杂志,2012,13(3):240–242. DOI:10.16506/j.1009−6639.2012.03.005.

    Qi X, Zhang Y, Wan X, et al. Design and application of public health policy evaluation[J]. Chin Prev Med, 2012, 13(3): 240–242. DOI: 10.16506/j.1009−6639.2012.03.005.
    [22] 詹思延. 流行病学[M]. 8版. 北京: 人民卫生出版社, 2017.

    Zhan SY. Epidemiology[M]. 8th ed. Beijing: People′s Medical Publishing House, 2017.
    [23] Källander K, Tibenderana JK, Akpogheneta OJ, et al. Mobile health (mHealth) approaches and lessons for increased performance and retention of community health workers in low- and middle-income countries: a review[J]. J Med Internet Res, 2013, 15(1): e17. DOI:  10.2196/jmir.2130.
    [24] Husain I, Spence D. Can healthy people benefit from health apps?[J]. BMJ, 2015, 350: h1887. DOI:  10.1136/bmj.h1887.
    [25] Marigorta UM, Rodríguez JA, Gibson G, et al. Replicability and prediction: lessons and challenges from GWAS[J]. Trends Genet, 2018, 34(7): 504–517. DOI:  10.1016/j.tig.2018.03.005.
    [26] Greenland S, Gago-Dominguez M, Castelao JE. The value of risk-factor (“black-box”) epidemiology[J]. Epidemiology, 2004, 15(5): 529–535. DOI:  10.1097/01.ede.0000134867.12896.23.
    [27] 李敏, 时景璞, 于慧会. 真实世界研究与随机对照试验、单病例随机对照试验在临床治疗性研究中的关系比较[J]. 中华流行病学杂志,2012,33(3):342–345. DOI:10.3760/cma.j.issn.0254−6450.2012.03.021.

    Li M, Shi JP, Yu HH. Relationship between the ‘Real World’ research, randomized controlled trial and number of one randomized controlled trial in clinical therapeutic study[J]. Chin J Epidemiol, 2012, 33(3): 342–345. DOI: 10.3760/cma.j.issn.0254−6450.2012.03.021.
    [28] 吴周志, 徐承中, 徐勇, 等. 健康医疗大数据下疾病监测报告模式的变革—宜昌市健康管理大数据分析中心建设的启示[J]. 疾病监测,2019,34(1):10–14. DOI:10.3784/j.issn.1003−9961.2019.01.005.

    Wu ZZ, Xu CZ, Xu Y, et al. Changes in disease surveillance reporting model based on health big data— inspirations from the construction of big data analysis center of health management in Yichang[J]. Dis Surveill, 2019, 34(1): 10–14. DOI: 10.3784/j.issn.1003−9961.2019.01.005.
    [29] 宋菁, 胡永华. 流行病学展望: 医学大数据与精准医疗[J]. 中华流行病学杂志,2016,37(8):1164–1168. DOI:10.3760/cma.j.issn.0254−6450.2016.08.022.

    Song J, Hu YH. Medical big data and precision medicine: prospects of epidemiology[J]. Chin J Epidemiol, 2016, 37(8): 1164–1168. DOI: 10.3760/cma.j.issn.0254−6450.2016.08.022.
    [30] Butler D. When Google got flu wrong[J]. Nature, 2013, 494(7436): 155–156. DOI:  10.1038/494155a.
    [31] Khoury MJ, Ioannidis JPA. Big data meets public health[J]. Science, 2014, 346(6213): 1054–1055. DOI:  10.1126/science.aaa2709.
    [32] 唐金陵, 李立明. 关于循证医学、精准医学和大数据研究的几点看法[J]. 中华流行病学杂志,2018,39(1):1–7. DOI:10.3760/cma.j.issn.0254−6450.2018.01.001.

    Tang JL, Li LM. Some reflections on evidenced-based medicine, precision medicine, and big data-based research[J]. Chin J Epidemiol, 2018, 39(1): 1–7. DOI: 10.3760/cma.j.issn.0254−6450.2018.01.001.
    [33] 付之鸥, 鲍昌俊, 李中杰, 等. 基于“大数据”的流感预警研究进展[J]. 中华流行病学杂志,2020,41(6):975–980. DOI:10.3760/cma.j.cn112338−20190908−00657.

    Fu ZO, Bao CJ, Li ZJ, et al. Progress of research regarding the influenza early warning system, based on “Big Data”[J]. Chin J Epidemiol, 2020, 41(6): 975–980. DOI: 10.3760/cma.j.cn112338−20190908−00657.
    [34] Lazer D, Kennedy R, King G, et al. The parable of Google Flu: traps in big data analysis[J]. Science, 2014, 343(6176): 1203–1205. DOI:  10.1126/science.1248506.
    [35] Ginsberg J, Mohebbi MH, Patel RS, et al. Detecting influenza epidemics using search engine query data[J]. Nature, 2009, 457(7232): 1012–1014. DOI:  10.1038/nature07634.
  • 加载中
计量
  • 文章访问数:  792
  • HTML全文浏览量:  224
  • PDF下载量:  91
  • 被引次数: 0
出版历程
  • 收稿日期:  2020-10-27
  • 网络出版日期:  2021-03-09
  • 刊出日期:  2021-04-07

目录

    /

    返回文章
    返回

    在线交流

    防诈骗公告

    大家好:近期有不法分子以本刊编辑身份添加作者微信,请务必提高警惕!本刊关于稿件的一切事项通知均采用编辑部唯一邮箱(jbjc@icdc.cn)和座机(010-58900732)联系作者,且在录用稿件后仅收取版面费,无其他任何名目费用(如审稿费和加急费等),非编辑部邮箱发送的本刊收费用通知等均为诈骗,不要随意汇入款项!如有可疑及时致电编辑部核实确认!